Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN12525141
ISRCTN12525141
Active, not recruiting
未知

Evaluation of the marginal bone level change of Straumann Bone Level Tapered® implants using different screwed abutment height in partially edentulous patients: a randomized controlled clinical trial

niversitat Internacional de Catalunya0 sites98 target enrollmentMay 26, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrevention of marginal bone loss around fixed implant restorations in partially edentulous patientsOral Health

Overview

Phase
未知
Intervention
Not specified
Conditions
Prevention of marginal bone loss around fixed implant restorations in partially edentulous patients
Sponsor
niversitat Internacional de Catalunya
Enrollment
98
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2023
End Date
June 30, 2027
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitat Internacional de Catalunya

Eligibility Criteria

Inclusion Criteria

  • •1\. Signed informed consent
  • •2\. Overall, healthy subjects
  • •3\. Females and males of at least eighteen\-years
  • •4\. Requiring a minimum of two implants (molar and/or premolar teeth)
  • •5\. Adequate oral hygiene (less than 15% FMPS)
  • •6\. Able to follow instructions and attend a regular compliance
  • •7\. Enough bone to place a standard implant of 4\.1 mm diameter

Exclusion Criteria

  • •1\. Acute local infection
  • •2\. Occlusal overload with parafunctional activity (assessed clinically)
  • •3\. Large occlusal discrepancies
  • •4\. Untreated periodontal disease assessed by Socransky et al. parameters (\=2mm clinical attachment loss in two consecutive visits within 1 year)
  • •5\. Smokers (more than 10 cigarettes/day)
  • •6\. Drug and/or alcoholic dependencies
  • •7\. Medical conditions contraindicating implant surgery
  • •8\. History of head and/or neck radiation
  • •9\. Bisphosphonate therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Evaluation of marginal bone level around short maxillary implants
IRCT2017021025662N2Vice chancellor for research, Tehran University of Medical Sciences16
Recruiting
Not Applicable
Evaluation of two types of implants installed in the jawPatients with partially edentulous jaw that need to be restored with single crownsC05.500.480.450
RBR-6c2k3mniversidade de São Paulo
Completed
Phase 3
Bone density changes before and after administration of danozoomab
IRCT20210803052067N1Artesh University of Medical Sciences202
Completed
Early Phase 1
Comparison of one vs two implant overdentutresbone loss.Other specified disorders of bone density and structure
IRCT201010265029N1Dental School, Hamadan Medical Science University20
Active, not recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.
EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46